Pat Dorsey - Dorsey Asset Management
| History | Stock | % of Portfolio |
Recent Activity |
Shares | Avg. Buy Price* |
Value | Current Price |
+/- Since Buy |
52 Week Low |
52 Week High |
|---|---|---|---|---|---|---|---|---|---|---|
| ☰ | ASML - ASML Holdings N.V. | 14.76 | Reduce 27.06% | 140,295 | $805.97 | $185,305,845 | $1,726.04 | 114.16% | $679.89 | $1,999.96 |
| ☰ | AER - AerCap Holdings N.V. | 12.27 | Reduce 7.54% | 1,123,489 | $104.60 | $154,120,221 | $149.14 | 42.59% | $104.82 | $155.99 |
| ☰ | SUNB - Sunbelt Rentals Holdings, Inc. | 11.43 | Buy | 2,204,996 | $65.09 | $143,523,190 | $73.82 | 13.41% | $60.40 | $85.79 |
| ☰ | APP - AppLovin Corp. | 10.04 | Buy | 316,952 | $398.00 | $126,146,896 | $442.85 | 11.27% | $342.11 | $745.61 |
| ☰ | DHR - Danaher Corp. | 8.76 | Reduce 29.88% | 580,240 | $214.13 | $110,013,504 | $200.16 | -6.53% | $160.60 | $241.78 |
| ☰ | RPRX - Royalty Pharma plc | 8.70 | Add 0.76% | 2,276,570 | $35.38 | $109,207,063 | $56.45 | 59.57% | $33.57 | $58.84 |
| ☰ | SPGI - S&P Global Inc. | 7.54 | Buy | 222,683 | $402.40 | $94,715,987 | $437.84 | 8.81% | $359.36 | $543.27 |
| ☰ | LYV - Live Nation Entertainment, Inc. | 7.38 | Add 0.77% | 607,609 | $142.58 | $92,666,449 | $183.25 | 28.53% | $125.34 | $188.00 |
| ☰ | META - Meta Platforms, Inc. | 7.37 | Add 0.77% | 161,683 | $239.78 | $92,503,695 | $656.73 | 173.89% | $519.78 | $793.65 |
| ☰ | UBER - Uber Technologies, Inc. | 6.24 | Buy | 1,090,281 | $71.93 | $78,423,912 | $74.26 | 3.24% | $67.19 | $101.99 |
| ☰ | BKNG - Booking Holdings Inc. | 5.51 | Add 0.78% | 411,100 | $190.11 | $69,234,502 | $175.80 | -7.53% | $149.76 | $229.86 |
* Avg. Buy Price is an estimated cost basis: the share-weighted average of the quarter-end prices reported when this
manager first bought or later added to the position (average-cost method, reset after a full exit). 13F filings disclose only
quarter-end holdings, not actual trade prices, so this approximates — but does not exactly equal — what was paid.
Sector % analysis
Communication Services
24.79
Industrials
23.70
Technology
21.00
Healthcare
17.46
Financial Services
7.54
Consumer Cyclical
5.51